Actively Recruiting

Age: 18Years - 65Years
All Genders
ID07329595

Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury

Led by Tamas Vegh, MD · Updated on 2026-01-09

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Severe burn injuries can cause significant stress and damage to the intestines, leading to changes in the gut microbiome that may affect immune responses and recovery. This research aims to monitor how the gut microbiome changes over time after a severe burn injury and how these changes relate to inflammation, organ function, and patient outcomes such as infection rates and wound healing. Patients with severe burns involving more than 20% of their body or inhalation injuries are enrolled shortly after hospital admission. Fecal samples are collected initially and then once or twice a week for up to 12 weeks, following standard nutritional and intensive care protocols. The study analyzes the diversity and composition of gut bacteria using advanced DNA sequencing techniques to understand how the microbiome evolves during recovery. Participants undergo regular fecal sampling alongside weekly laboratory tests during their hospital stay. Researchers track changes in gut bacteria diversity and measure related inflammatory, endocrine, hematological, and immunological markers. Clinical outcomes such as survival, length of hospital stay, mechanical ventilation duration, infection rates, organ failure severity, and wound healing are also monitored throughout the study period.

CONDITIONS

Brief Title

Monitoring the Clinical and Immunological Effects of Microbiome Changes Following Severe Burn Injury

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged between 18 and 65 years
  • Diagnosed with severe burn injury involving more than 20% of the total body surface area and/or inhalation injury
  • Burn caused by scalding, flame, electrical, contact, or chemical exposure
  • Hospital admission within 24 hours following injury
Not Eligible

You will not qualify if you...

  • Patients with inflammatory bowel diseases or malignant tumors
  • Patients with a history of major stomach or intestinal surgery
  • Patients with a pre-injury ECOG performance status of 4

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - Up to 12 weeks

Participants who have experienced severe burn injury are observed through regular fecal sample collection and laboratory investigations to assess changes in gut microbiome diversity and related clinical and immunological effects.

Weekly visits with one to two fecal sample collections per week and weekly laboratory investigations

Trial Site Locations

Total: 1 location

1

University of Debrecen, Department of Anesthesiology and Intensive Care

Debrecen, Hajdú-Bihar, Hungary, 4032

Actively Recruiting

Loading map...

Research Team

L

Lenke Jenei Kluch, MD

E

Erzsebet Igbonu-Nagy, BSC

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Effects of Dietary Fats on Gut Microbiota Composition and Me...

Short Chain Fatty Acids Concentration in Stools

Actively Recruiting

1 location

The Effect of Vitamin C Supplementation on Gut Microbiota Co...

Short Chain Fatty Acids Concentration in Stools

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit.

Myung Jin Song, Seok Kim, Dachung Boo...

https://pubmed.ncbi.nlm.nih.gov/34531488

Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study.

H Tanaka, T Matsuda, Y Miyagantani...

https://pubmed.ncbi.nlm.nih.gov/10722036